Cocrystal Pharma Files 8-K
Ticker: COCP · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1412486
| Field | Detail |
|---|---|
| Company | Cocrystal Pharma, INC. (COCP) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financial-statements
TL;DR
Cocrystal Pharma filed an 8-K for March 31, 2025, mostly financial updates.
AI Summary
Cocrystal Pharma, Inc. filed an 8-K on April 1, 2025, reporting events as of March 31, 2025. The filing primarily concerns financial statements and exhibits, with no specific material events detailed in the provided text.
Why It Matters
This 8-K filing indicates Cocrystal Pharma, Inc. is providing updated financial statements and exhibits to the SEC, which is a standard regulatory requirement.
Risk Assessment
Risk Level: low — The filing appears to be routine financial reporting and does not disclose any significant new risks or material adverse events.
Key Players & Entities
- Cocrystal Pharma, Inc. (company) — Registrant
- BIOZONE PHARMACEUTICALS, INC. (company) — Former company name
- International Surf Resorts, Inc. (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on 'Other Events' and to provide 'Financial Statements and Exhibits' as of March 31, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 31, 2025.
What is the principal executive office address for Cocrystal Pharma, Inc.?
The principal executive offices are located at 19805 N. Creek Parkway, Bothell, WA 98011.
What is the IRS Employer Identification Number for Cocrystal Pharma, Inc.?
The IRS Employer Identification Number for Cocrystal Pharma, Inc. is 35-2528215.
What are the former names of Cocrystal Pharma, Inc.?
Cocrystal Pharma, Inc. was formerly known as BIOZONE PHARMACEUTICALS, INC. and International Surf Resorts, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Cocrystal Pharma, Inc. (COCP).